A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma
口服p-STAT3抑制剂WP1066治疗复发性恶性胶质瘤患者的首次人体I期临床试验
期刊:CNS oncology
影响因子:
doi:10.2217/cns-2022-0005
Groot, John de; Ott, Martina; Wei, Jun; Kassab, Cynthia; Fang, Dexing; Najem, Hinda; O'Brien, Barbara; Weathers, Shiao-Pei; Matsouka, Carlos Kamiya; Majd, Nazanin K; Harrison, Rebecca A; Fuller, Gregory N; Huse, Jason T; Long, James P; Sawaya, Raymond; Rao, Ganesh; MacDonald, Tobey J; Priebe, Waldemar; DeCuypere, Michael; Heimberger, Amy B